Delay in AIM Admission
08 Febrero 2007 - 11:40AM
UK Regulatory
RNS Number:9858Q
GeneMedix PLC
08 February 2007
8 February 2007
GeneMedix Plc
Delay of cancellation of listing on the Official List and Admission to AIM
GeneMedix plc ("GeneMedix" or "the Company"), the UK biopharmaceutical company
listed on the London and Singapore Stock Exchanges, announces that, owing to a
delay in satisfying completion requirements for the Proposal, it is now expected
that the final day of trading of the Company's shares on the Official List will
be 15 February 2007 and that the Admission to AIM and consolidation of the
Company's ordinary shares will take place on 16 February 2007.
ENQUIRIES:
GeneMedix plc Tel: 01638 663320
Julian Attfield, Chief Executive Officer
Bankside Consultants Tel: 020 7367 8888
Susan Scott / Daniela Hale
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCDVLFBDLBXBBK
Reliance Genemedix (LSE:GMX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Reliance Genemedix (LSE:GMX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Reliance Gen. (London Stock Exchange): 0 recent articles
Más de Genemedix Plc Artículos de Noticias